Primary analysis of nasopharyngeal carcinoma patient's peripheral blood whole-genome microarray

LUO Dong-hua,CAO Jing-yan,JI Hong,ZHANG Hua,ZENG Mu-sheng,HONG Ming-huang
DOI: https://doi.org/10.16073/j.cnki.cjcpt.2011.09.010
2011-01-01
Abstract:OBJECTIVE: To compare whole-genome expression differences between healthy control and nasopharynged carcinoma patient,and screen mRNA molecular biomarkers in peripheral blood of nasopharyngeal carcinoma patients.METHODS:Twenty cases of nasopharyngeal carcinoma(NPC) patients and 20 cases of healthy control which were matched in sex and age,were entered the study.mRNA was extracted from whole peripheral blood sample by QIAGEN RNeasy○R Mini Kit and then using Agilent gene oligonucleotide microarray to detect differentially expressed genes between the two groups.Using t-test unequal unpaired algorithm of Gene Spring 10.0 software to calculate differentially expressed genes when P<0.05 and sort by fold change.Gene Spring and DAVID Bioinformatics Resources 6.7 were used for clustering,GO analysis,Pathway analysis;Classification and function of different genes were illustrated.RESULTS: For fold change larger than 1.5,there 1 257 probes(up regulation 687,down regulation 570);for fold change larger than 2.0,there are 171 probes(up regulation 132,down regulation 39).They were mostly related to cell cycle,immune response and reaction to the virus.They were mainly involved in cancer pathway,cell cycle pathway,p53 signaling pathway.CONCLUSIONS: Whole-genome microarray can detect differentially expressed genes in peripheral blood between NPC patients and healthy control.mRNA molecular biomarkers should be found after deeper analysis.
What problem does this paper attempt to address?